Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Gr... ( SAN FRANCISCO Aug. 7 2012 /- Nek...)

HOME >> MEDICINE >> TECHNOLOGY

Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma

Date:8/7/2012

SAN FRANCISCO, Aug. 7, 2012 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today the start of a Phase 2 study of etirinotecan pegol in patients with bevacizumab (Avastin)-resistant high-grade glioma being conducted at Stanford Cancer Institute. The Phase 2 study is an investigator-sponsored trial being conducted under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigators Seema Nagpal, M.D. and Pamela Kunz, M.D.

"Patients with bevacizumab-resistant high-grade glioma currently have little to no treatment options to help them manage their disease," said Dr. Recht. "We know that the mechanism of topoisomerase I inhibition has resulted in anti-tumor activity in gliomas in the past. As a result, we are interested in evaluating etirinotecan pegol, this new targeted topoisomerase I inhibitor, which provides sustained exposure of drug metabolite to tumor cells."

The primary endpoint of the Phase 2 study is the six-week progression free survival (PFS) rate. Secondary endpoints include survival from time of first etirinotecan pegol infusion, overall survival from date of pathologic diagnosis or confirmation of high-grade glioma, and the safety profile of etirinotecan pegol in patients with bevacizumab-resistant high-grade glioma. The open label, single-arm trial is expected to enroll approximately 20 patients who will receive etirinotecan pegol once every three weeks as monotherapy.

"Etirinotecan pegol has demonstrated promising results in drug-resistant solid tumors, such as advanced and heavily pre-treated breast and ovarian cancers," said Robert Medve, M.D., Senior Vice President and Chief Medical Officer of Nektar Therapeutics. "Recognizing the high unmet need in glioma, we are very pleased to support Dr. Recht and his colleagues with this study of single-agent etirinotecan pegol in this se
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center

Post Your Comments:

(Date:5/24/2013)... , May 24, 2013 Solta Medical, Inc. ... medical aesthetics market, today reported Dr. Edward W. ... Company,s Board of Directors effective immediately. Dr. Knowlton is the ... had served as a director since 1996. "On ... our management team, I would like to thank Ed for ...

(Date:5/24/2013)... Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider ... Robert Grieve , the Company,s chairman and ... executive vice president and chief financial officer, will present at ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 1:30 p.m. EDT. ...

(Date:5/24/2013)... May 24, 2013 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel. Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3 Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4

[0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference [0] Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference

... 26, 2011 Sysmex, a global leader in ... today announced that Andrew (Andy) Hay has been ... effective immediately. Hay, a long-time Sysmex employee, is ... corporate accounts, sales training and sales operational activities ...

... The virtual event Design Trends: Technological Advances in Implantable ... until 5pm Eastern time. Registration is available here ... The combined virtual conference and tradeshow kicks-off this ... address by Venkat Rajan, Industry Manager of Medical Devices ...

Cached Medicine Technology:Sysmex America Appoints Vice President of Sales 2 Live Today: Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 2

Sysmex America Appoints Vice President of Sales Live Today: Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices

(Date:5/25/2013)... (PRWEB) May 25, 2013 Radius ... underground shelter company in the US and has ... structures for over 35 years. M.E. and President, ... Handbook of NBC Weapon Fundamentals and Shelter Engineering ... States’ bible on shelter engineering. McCarthy is considered ...

(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 On ... that many people do not wish to discuss or plan ... in life. FuneralFinancials.com released a Must-Do List ... , 1. Funeral Financials recommends, “Creating a personal fact sheet.” ... used to organize financial information and personal data. It ...

(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...

(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...

(Date:5/25/2013)... Prairie Living at Chautauqua , a BMA ... Cross Blood Drive from 1:30 to 5:30 p.m. on ... at 955 Villa Ct. in Carbondale, Illinois, serves older ... need some help to maintain their independence.. , "Come ... Frey, Director of Marketing for Prairie Living. , For ...

Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2 Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3 Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2 Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2

[0] Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster [0] FuneralFinancials.com Releases Last Wishes Must-Do List [0] Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive

... ... ... ... ...

... Freedom Healthnet today ... of new products. , ... UK (PRWEB) February 19, 2010 -- Freedom Healthnet ( http://www.freedomhealthnet.com/ ) today affirmed the benefits ... , ,Freedom Healthnet is already a market leader in the UK for health insurance, providing ...

... ... present a talk on the False Claims Act to the Great Salt Lake Chapter of ... Clearfield. Terry will discuss the "nuts and bolts" of the False Claims Act, its ... ...

... ... ... ... ...

... , ... ... ... ...

... ... a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, ... ... of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly ...

Nuvo Research announces 2009 fourth quarter and year-end financial results Freedom Healthnet Affirms Affordable Private Health Insurance Benefits Great Salt Lake Chapter of National Contract Management Association Hosts Presentation on False Claims Act by Qui Tam Attorney Tim Terry FDA Cancer Drug Approval Rate Highlighted in JNCI Centene Corporation to Webcast Medical Management Systems Update UCSF Enters Drug Discovery Agreement with Genentech

... the new large power line from ... both cordless AND electric instruments, offering ... versatility the industry has always wanted ... name. Power Master reciprocating ...

The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....

The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...

... The SmartDriver System consists of a ... Battery Power, with a wide range of ... variety of orthopedic surgical applications., ,The ... and speed compared to the original Battery ...

Medicine Products:

Powermaster Reciprocating Saw Large Power Battery/Electric Reciprocating Saw Large Power Battery/Electric Drill Reamer Battery SmartDriver XT